News
12-04-2007, 03:45 AM
WASHINGTON(Reuters) - The benefits of Roche Holding AG's cancerdrug Avastin in breast cancer should be weighed against some toxicside effects including the potential for death, U.S. regulatorystaffers said in documents released on Monday.
More... (http://www.healthcentral.com/breast-cancer/news-196687-66.html)
More... (http://www.healthcentral.com/breast-cancer/news-196687-66.html)